RICHARD ROBERT WILSON, M.D.
Osteopathic Medicine at Nursery Hill Ln, Saint Paul, MN
License number
Minnesota 30699
Category
Osteopathic Medicine
Type
General Practice
Address
Address
1276 Nursery Hill Ln, Saint Paul, MN 55112
Phone
(651) 260-8042
Personal information
See more information about RICHARD ROBERT WILSON at radaris.comName
Address
Phone
515 Brockton Ln N, Minneapolis, MN 55447
90 7Th St, Minneapolis, MN 55402
6820 Meadowbrook Blvd, Minneapolis, MN 55426
34372 Highway 47 NW, Cambridge, MN 55008
2576 Upton Ave S, Minneapolis, MN 55405
Organization information
See more information about RICHARD ROBERT WILSON at bizstanding.comRichard Robert Wilson M.D
1276 Nursery Hl Ln, Saint Paul, MN 55112
Industry:
Medical Doctor's Office
Medical Doctor:
Richard R. Wilson (Medical Doctor)
Professional information
See more information about RICHARD ROBERT WILSON at trustoria.com
Nerve Blocking For Treatment Of Gastrointestinal Disorders
Nerve Blocking For Treatment Of Gastrointestinal Disorders
US Patent:
8010204, Aug 30, 2011
Filed:
Mar 11, 2010
Appl. No.:
12/721603
Inventors:
Mark B. Knudson - Shoreview MN, US
Richard R. Wilson - Arden Hills MN, US
Katherine S. Tweden - Mahtomedi MN, US
Timothy R. Conrad - Eden Prairie MN, US
Richard R. Wilson - Arden Hills MN, US
Katherine S. Tweden - Mahtomedi MN, US
Timothy R. Conrad - Eden Prairie MN, US
Assignee:
EnteroMedics Inc. - St. Paul MN
International Classification:
A61N 1/08
US Classification:
607 59, 607 40
Abstract:
A system comprising: at least one electrode adapted to be placed on a vagus nerve below a vagal innervation of the heart; an implantable controller comprising an induction coil, at least one circuit for generating a neural conduction blocking signal connected to the at least one electrode, a battery, and a central processing unit comprising program storage and memory; and an external programmer configured to: communicate at least one parameter for the neural conduction blocking signal to the implantable controller, wherein the parameter is selected for the neural conduction blocking signal to i) at least partially downregulate the vagus nerve, ii) allow at least partial recovery of the nerve activity following discontinuation of the neural conduction blocking signal, and iii) reduce pancreatic and biliary output via inhibition of pancreo-biliary output; and an external coil adapted to be worn by the patient, wherein the external coil is connected to the external programmer, and is adapted to inductively couple to the induction coil of the implantable controller.
Nerve Stimulation And Blocking For Treatment Of Gastrointestinal Disorders
Nerve Stimulation And Blocking For Treatment Of Gastrointestinal Disorders
US Patent:
8538542, Sep 17, 2013
Filed:
Jul 21, 2011
Appl. No.:
13/188293
Inventors:
Mark B. Knudson - Shoreview MN, US
Richard R. Wilson - Arden Hills MN, US
Katherine S. Tweden - Mahtomedi MN, US
Timothy R. Conrad - Eden Prairie MN, US
Richard R. Wilson - Arden Hills MN, US
Katherine S. Tweden - Mahtomedi MN, US
Timothy R. Conrad - Eden Prairie MN, US
Assignee:
EnteroMedics Inc. - St. Paul MN
International Classification:
A61N 1/08, A61N 1/36
US Classification:
607 59, 607 40
Abstract:
Systems and methods of using a system for treating a gastrointestinal disorder characterized by dysmotility of a gastrointestinal organ. A system comprises a first electrode adapted for placement on the vagus nerve at a stimulation site proximal to at least one site of vagal innervation of a gastrointestinal organ, a second electrode adapted for placement on the vagus nerve at a site proximal to the stimulation site, a third electrode adapted for placement on the vagus nerve at a distal blocking site distal to the stimulation site, an implantable controller comprising at least one circuit for generating a neural conduction blocking signal connected to the second and third electrode, at least one circuit for generating a neural conduction stimulating signal connected to the first electrode; and an external programmer configured to communicate at least one parameter for the neural conduction blocking signal to the implantable controller; and an external coil adapted to be worn by the patient, wherein the external coil is connected to the external programmer, and is adapted to inductively couple to the implantable controller.
Controlled Vagal Blockage Therapy
Controlled Vagal Blockage Therapy
US Patent:
8538533, Sep 17, 2013
Filed:
Oct 19, 2011
Appl. No.:
13/276638
Inventors:
Mark B. Knudson - Shoreview MN, US
Richard R. Wilson - Arden Hills MN, US
Katherine S. Tweden - Mahtomedi MN, US
Timothy R. Conrad - Eden Prairie MN, US
Richard R. Wilson - Arden Hills MN, US
Katherine S. Tweden - Mahtomedi MN, US
Timothy R. Conrad - Eden Prairie MN, US
Assignee:
EnteroMedics Inc. - St. Paul MN
International Classification:
A61N 1/36
US Classification:
607 40, 607 62
Abstract:
Systems and methods for treating at least one of a plurality of disorders characterized at least in part by vagal activity. In embodiments, a method for treating obesity comprises positioning a first electrode on a vagus nerve of an obese patient at a location below a vagal innervation of the heart; treating the patient's obesity by applying an electrical treatment signal to the electrode with the electrical treatment signal having: a frequency selected for the signal to at least partially downregulate nerve impulses on the vagal nerve, wherein the signal has a frequency in excess of 200 Hz, and without simultaneously applying a neural impulse-inducing secondary electrical signal to the vagus nerve on a proximal side of the location whenever the electrical treatment signal is applied; and b) a plurality of on-times separated by a plurality of off-times, the signal applied during the on-times and not applied during the off-times, wherein the duration of the off-times is selected in response to a signal from a sensing electrode representing at least 50% of the activity of the vagal nerve as compared to baseline.
Vagal Down-Regulation Obesity Treatment
Vagal Down-Regulation Obesity Treatment
US Patent:
7489969, Feb 10, 2009
Filed:
Sep 29, 2003
Appl. No.:
10/674330
Inventors:
Mark B. Knudson - Shoreview MN, US
Richard R. Wilson - Arden Hills MN, US
Katherine S. Tweden - Mahtomedi MN, US
Timothy R. Conrad - Eden Prairie MN, US
Richard R. Wilson - Arden Hills MN, US
Katherine S. Tweden - Mahtomedi MN, US
Timothy R. Conrad - Eden Prairie MN, US
Assignee:
EnteroMedics Inc. - St. Paul MN
International Classification:
A61N 1/18
US Classification:
607 40
Abstract:
Obesity is treated by applying a non-ablative, non-systemic therapy to a vagus nerve of an obese patient at a site below a vagal innervation of a heart. The therapy is selected to at least partially down-regulate a neural activity on the vagus nerve of the obese patient. The therapy is applied in a manner to down-regulate at least afferent signals on the vagus nerve.
Neural Signal Duty Cycle
Neural Signal Duty Cycle
US Patent:
2008028, Nov 13, 2008
Filed:
May 9, 2007
Appl. No.:
11/746286
Inventors:
Katherine S. Tweden - Mahtomedi MN, US
Richard R. Wilson - Arden Hills MN, US
Christopher C. Pulling - Princeton MN, US
Richard R. Wilson - Arden Hills MN, US
Christopher C. Pulling - Princeton MN, US
International Classification:
A61N 1/05
US Classification:
607 2
Abstract:
A disorder (e.g., obesity) is treated by applying an electrical signal to an autonomic nerve (e.g., a vagus or splanchnic nerve). The treatment includes applying a signal to a nerve of a patient to be treated. The signal has a duty cycle including an ON time during which the signal is applied by to the nerve followed by an OFF time during the signal is not applied to the nerve. The ON time is selected to have a duration preferably greater than 30 seconds and up to 180 seconds.
Devices And Methods For Detecting And Treating Inadequate Tissue Perfusion
Devices And Methods For Detecting And Treating Inadequate Tissue Perfusion
US Patent:
7097618, Aug 29, 2006
Filed:
Mar 9, 2004
Appl. No.:
10/797584
Inventors:
David G. Benditt - Edina MN, US
Brian P. Brockway - Shoreview MN, US
Richard R. Wilson - Arden Hills MN, US
Brian P. Brockway - Shoreview MN, US
Richard R. Wilson - Arden Hills MN, US
Assignee:
Transoma Medical, Inc. - St. Paul MN
International Classification:
A61B 5/05, A61B 5/00
US Classification:
600363, 600300
Abstract:
Devices and methods for detecting inadequate tissue perfusion by measuring a parameter other than heart rate such as vascular blood pressure, intracardiac blood pressure, vascular blood flow or tissue perfusion, in addition to or as a substitute for heart rate. Such devices and methods improve the accuracy of determining when and to what degree therapy should be administered to treat inadequate tissue perfusion, such as pre-syncope, syncope, or orthostatic hypotension, particularly in the absence of abnormal cardiac function.
Nerve Stimulation And Blocking For Treatment Of Gastrointestinal Disorders
Nerve Stimulation And Blocking For Treatment Of Gastrointestinal Disorders
US Patent:
7729771, Jun 1, 2010
Filed:
Aug 13, 2007
Appl. No.:
11/891770
Inventors:
Mark B. Knudson - Shoreview MN, US
Richard R. Wilson - Arden Hills MN, US
Katherine S. Tweden - Mahtomedi MN, US
Timothy R. Conrad - Eden Prairie MN, US
Richard R. Wilson - Arden Hills MN, US
Katherine S. Tweden - Mahtomedi MN, US
Timothy R. Conrad - Eden Prairie MN, US
Assignee:
EnteroMedics Inc. - St. Paul MN
International Classification:
A61N 1/05
US Classification:
607 40
Abstract:
At least one of a plurality of gastrointestinal disorders is treated by stimulating an enteric nervous system of a patient to enhance a functional tone of the enteric nervous system. A treatment includes electrically stimulating a vagus nerve of the patient at a stimulation site proximal to at least one site of vagal innervation of a gastrointestinal organ. The electrical stimulation includes applying a stimulation signal at the stimulation site. An optional proximal electrical blocking signal is applied to the vagus nerve at a proximal blocking site proximal to the stimulation site. The proximal blocking signal is selected to at least partially block nerve impulses at the proximal blocking site.
High Frequency Obesity Treatment
High Frequency Obesity Treatment
US Patent:
7844338, Nov 30, 2010
Filed:
Jun 30, 2004
Appl. No.:
10/881045
Inventors:
Mark B. Knudson - Shoreview MN, US
Richard R. Wilson - Arden Hills MN, US
Katherine S. Tweden - Mahtomedi MN, US
Timothy R. Conrad - Eden Prairie MN, US
Richard R. Wilson - Arden Hills MN, US
Katherine S. Tweden - Mahtomedi MN, US
Timothy R. Conrad - Eden Prairie MN, US
Assignee:
EnteroMedics Inc. - St. Paul MN
International Classification:
A61N 1/18
US Classification:
607 40
Abstract:
A method for treating at least one of a plurality of disorders characterized at least in part by vagal activity includes positioning an electrode around a body organ innervated by the vagus. An electrical signal is applied to the electrode to modulate vagal activity. The electrical signal is applied at a frequency selected for the signal to create a neural conduction block to the vagus with the neural conduction block selected to at least partially block nerve impulses on the vagus. The application of the electrical signal is discontinued. The application of the signal and the discontinuing of the signal are repeated with durations of the discontinuing and the application selected to treat the disorder.
Intraluminal Electrode Apparatus And Method
Intraluminal Electrode Apparatus And Method
US Patent:
7444183, Oct 28, 2008
Filed:
Jan 6, 2004
Appl. No.:
10/752940
Inventors:
Mark B. Knudson - Shoreview MN, US
Richard R. Wilson - Arden Hills MN, US
Katherine S. Tweden - Mahtomedi MN, US
Timothy R. Conrad - Eden Prairie MN, US
Richard R. Wilson - Arden Hills MN, US
Katherine S. Tweden - Mahtomedi MN, US
Timothy R. Conrad - Eden Prairie MN, US
Assignee:
EnteroMedics, Inc. - St. Paul MN
International Classification:
A61N 1/06
US Classification:
607 40, 607133
Abstract:
A patient is treated with electrode positioned within a lumen of an esophagus of the patient and positioned at a mucosal layer of the esophagus. An electrical signal is applied to the electrode to to create a neural conduction block on a vagal trunk external to the esophagus.
Obesity And Eating Disorder Stimulation Treatment With Neural Block
Obesity And Eating Disorder Stimulation Treatment With Neural Block
US Patent:
2005007, Mar 31, 2005
Filed:
Jan 12, 2004
Appl. No.:
10/756176
Inventors:
Mark Knudson - Shoreview MN, US
Richard Wilson - Arden Hills MN, US
Katherine Tweden - Mahtomedi MN, US
Timothy Conrad - Eden Prairie MN, US
Richard Wilson - Arden Hills MN, US
Katherine Tweden - Mahtomedi MN, US
Timothy Conrad - Eden Prairie MN, US
International Classification:
A61N001/18
US Classification:
607058000
Abstract:
A method and apparatus for treating patients suffering from obesity or eating disorders by applying a predetermined stimulating signal to the patient's vagus nerve appropriate to alleviate the condition and by applying a neural conduction block to the vagus nerve at a blocking site with the neural conduction block selected to at least partially block nerve impulses on the vagus nerve at the blocking site.